Klotho Neurosciences
(NASDAQ) KLTO
Klotho Neurosciences Financials at a Glance
Market Cap
$33.83MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Revenue (TTM)
$0.00
Net Income (TTM)
-$22.17M
EPS (TTM)
-$0.34
P/E Ratio
-0.73
Dividend
$0.00
Beta (Volatility)
0.53 (Low)
Dividend
$0.00
Beta (Volatility)
0.53 (Low)
Price
$0.24
Volume
1,978,805.617
Open
$0.25
Price
$0.24
Volume
1,978,805.617
Open
$0.25
Previous Close
$0.24
Daily Range
$0.24 - $0.25
52-Week Range
$0.21 - $1.38
Estimated Earnings Date
Mar 30, 2026
Dividend
$0.00
Beta (Volatility)
0.53 (Low)
Price
$0.24
Volume
1,978,805.617
Open
$0.25
Previous Close
$0.24
Daily Range
$0.24 - $0.25
52-Week Range
$0.21 - $1.38
Estimated Earnings Date
Mar 30, 2026
KLTO News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Klotho Neurosciences
Industry
Biotechnology
Sector
Health CareEmployees
5
CEO
Joseph Sinkule, PharmD
Website
www.klothoneuro.comHeadquarters
Omaha, NE 68144, US
KLTO Financials
Key Financial Metrics (TTM)
Gross Margin
0.00%
Operating Margin
0.00%
Net Income Margin
0.00%
Return on Equity
-108.82%
Return on Capital
-75.51%
Return on Assets
-37.12%
Earnings Yield
-1.37%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$33.83MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Shares Outstanding
138.13M
Volume
1.98M
Avg. Volume
3.55M
Financials (TTM)
Gross Profit
$0.00
Operating Income
-$15.07M
EBITDA
-$15.38M
Operating Cash Flow
-$9.60M
Capital Expenditure
$9.00
Free Cash Flow
-$9.60M
Cash & ST Invst.
$10.00M
Total Debt
$294.54K
Klotho Neurosciences Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
N/A
Gross Profit
$0.00
N/A
Gross Margin
0.00%
N/A
Market Cap
$33.83MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
N/A
Market Cap/Employee
$11.28M
N/A
Employees
3
N/A
Net Income
-$13.86M
-520.3%
EBITDA
-$9.51M
-466.2%
Quarterly Fundamentals
Total Cash
$10.00M
+1667.6%
Total Debt
$294.54K
-83.3%
Accounts Receivable
$0.00
N/A
Inventory
$0.00
N/A
Long Term Debt
$0.00
N/A
Short Term Debt
$294.54K
-83.3%
Return on Assets
-37.12%
N/A
Return on Invested Capital
-25.47%
N/A
Free Cash Flow
-$5.27M
-238.9%
Operating Cash Flow
-$5.27M
-238.9%